Hypertension Diagnostics Financial Statements
Hypertension Diagnostics Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | June |
© 2009 Morningstar, Inc. Financial Data provided by
Hypertension Diagnostics Income Statement
| 2009 | 2008 | 2007 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.5 | 0.6 | 1.9 |
| Gross Profit ($ mil.) | 0.5 | 0.5 | 1.8 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (0.2) | (0.7) | (0.5) |
| Diluted EPS (Net Income) | (0.01) | (0.02) | (0.01) |
Hypertension Diagnostics Stock Quote & Chart
11/05/09 13:42:04 EST •
NASDAQ OTC BB •
0.10
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Hypertension Diagnostics Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 8.09 | 2.38 | 7.01 |
| Price/Earnings Ratio | (10.00) | 27.93 | 25.51 |
| Price/Book Ratio | 6.28 | 2.79 | 6.74 |
| Price/Cash Flow Ratio | (10.60) | 12.82 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Hypertension Diagnostics Financial Ratios
Hypertension Diagnostics Competitive Intelligence
| Cardinal Health | CardioDynamics | OMRON | |
|---|---|---|---|
| Annual Sales ($ mil.) | 99,512.4 | 24.5 | 2,911.3 |
| Employees | 29,600 | 122 | 32,583 |
| Market Cap ($ mil.) | 10,610.7 | 9.9 | -- |
Competitive Landscape
